Skip to content

Creatine and Cognition: What the Research Can and Cannot Establish

November 20, 2026
Creatine and Cognition: What the Research Can and Cannot Establish

Memory, attention and processing speed are different outcomes. Examine the research alongside EFSA’s evaluation before turning interest into a claim.

Gloved laboratory worker preparing a glass slide beside a microscope

Gloved laboratory worker preparing a glass slide beside a microscope. Illustrative photograph; not a Creapure® product, an ACC facility or a documented supplement outcome. Photo: RDNE Stock project / Pexels License.

Mechanism and demonstrated outcomes are different

Creatine’s role in energy metabolism gives researchers a reason to investigate brain function. It does not alone demonstrate that a supplement improves memory, concentration or workplace performance.

Separate the rationale, the human findings and the statements supportable for the actual product. Interest at one level does not automatically establish the next.

Look inside the pooled evidence

A 2024 meta-analysis included 16 randomised trials across differing ages and health backgrounds, assessing several cognitive domains. It offers a useful research map, not a single result proving broad cognitive enhancement.

Ask who participated, whether sleep loss or illness was involved, which test was used and how the dose and duration compare with the proposed product. These details determine relevance.

Consider the claim evaluation as well

EFSA’s 2024 assessment concluded that a cause-and-effect relationship with improved cognitive function had not been established. Positive findings in parts of a literature do not necessarily substantiate a general benefit claim.

That assessment is also not a universal statement of every market’s rules. Check local requirements and avoid promises to prevent dementia, raise IQ or guarantee study or work performance.

Make uncertainty useful to readers

An evidence explainer can describe tests, limitations and unanswered questions, helping readers understand why conclusions differ. That is valuable ingredient education without promising a finished-product effect.

For development, choose a positioning supported by applicable information. Specifying Creapure® can address provenance and quality documentation, but does not resolve the separate question of cognitive efficacy.

Discuss your OEM concept with ACC Biotech

Discuss a research-informed creatine concept with ACC Biotech, starting with the target market, evidence scope and an appropriate OEM development brief.

Contact ACC Biotech · WhatsApp +852 5544 1314

Sources checked 14 November 2026. Ingredient specifications and finished-product requirements should be confirmed for the project.

Cover: Two people in protective clothing reviewing documents on a clipboard in a laboratory setting. Illustrative photograph; not a Creapure® product, an ACC facility or a documented supplement outcome. Photo: Artem Podrez / Pexels License. Photo source · Pexels License

Inline: Gloved laboratory worker preparing a glass slide beside a microscope. Illustrative photograph; not a Creapure® product, an ACC facility or a documented supplement outcome. Photo: RDNE Stock project / Pexels License. Photo source · Pexels License